Andrés Negro‐vilar
#142,768
Most Influential Person Now
Andrés Negro‐vilar's AcademicInfluence.com Rankings
Andrés Negro‐vilarbiology Degrees
Biology
#10195
World Rank
#13502
Historical Rank
Cell Biology
#473
World Rank
#485
Historical Rank
Molecular Biology
#1458
World Rank
#1485
Historical Rank
Neuroscience
#1558
World Rank
#1609
Historical Rank
Download Badge
Biology
Andrés Negro‐vilar's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Molecular and Cell Biology Stanford University
Similar Degrees You Can Earn
Why Is Andrés Negro‐vilar Influential?
(Suggest an Edit or Addition)Andrés Negro‐vilar's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tissue and cellular distribution of the extended family of protein kinase C isoenzymes (1992) (429)
- Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. (1999) (344)
- Anatomy and physiology of central galanin-containing pathways (1993) (331)
- Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. (1992) (284)
- Catecholaminergic modulation of luteinizing hormone-releasing hormone release by median eminence terminals in vitro. (1979) (269)
- Nitric oxide regulates luteinizing hormone-releasing hormone secretion. (1993) (240)
- An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. (2007) (219)
- Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma. (2010) (194)
- Galanin: a hypothalamic-hypophysiotropic hormone modulating reproductive functions. (1991) (182)
- Combined retrograde tracing and immunocytochemical identification of luteinizing hormone-releasing hormone- and somatostatin-containing neurons projecting to the median eminence of the rat. (1989) (174)
- Colocalization of galanin and luteinizing hormone-releasing hormone in a subset of preoptic hypothalamic neurons: anatomical and functional correlates. (1990) (163)
- Evidence for a role of prolactin in prostate and seminal vesicle growth in immature male rats. (1977) (161)
- Release of prostaglandin Es by hypothalamic tissue: evidence for their involvement in catecholamine-induced luteinizing hormone-releasing hormone release. (1979) (158)
- Glutamate receptors of the non-N-methyl-D-aspartic acid type mediate the increase in luteinizing hormone-releasing hormone release by excitatory amino acids in vitro. (1990) (148)
- Effect of angiotensin II on in vivo and in vitro release of anterior pituitary hormones in the female rat. (1981) (145)
- Changes in serum prolactin and gonadotropins during sexual development of the male rat. (1973) (143)
- Morphological characterization of immortalized hypothalamic neurons synthesizing luteinizing hormone-releasing hormone. (1991) (124)
- Sexual differences in the distribution of neurons coexpressing galanin and luteinizing hormone-releasing hormone in the rat brain. (1991) (117)
- Role of oxytocin on prolactin secretion during proestrus and in different physiological or pharmacological paradigms. (1988) (114)
- Evidence that pulsatile follicle-stimulating hormone secretion is independent of endogenous luteinizing hormone-releasing hormone. (1986) (114)
- Passive immunoneutralization of endogenous inhibin: sex-related differences in the role of inhibin during development (1988) (107)
- Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms. (1997) (106)
- Endogenous excitatory amino acid neurotransmission regulates the estradiol-induced LH surge in ovariectomized rats. (1990) (106)
- Galanin stimulates luteinizing hormone-releasing hormone secretion from arcuate nucleus-median eminence fragments in vitro: involvement of an alpha-adrenergic mechanism. (1990) (105)
- Immunocytochemical localization of inhibin in rat and human reproductive tissues (1987) (104)
- Stress and other environmental factors affecting fertility in men and women: overview. (1993) (104)
- Gonadotropin-releasing hormone neuronal cell lines. (1992) (103)
- Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin. (1983) (96)
- Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II. (2008) (95)
- Responses in the brain of estrogen receptor alpha-disrupted mice. (1997) (94)
- Endogenous galanin modulates the gonadotropin and prolactin proestrous surges in the rat. (1993) (90)
- Dopamine and norepinephrine stimulate somatostatin release by median eminence fragments in vitro. (1978) (90)
- Serotonin and adrenocorticotropin (ACTH) release: direct effects at the anterior pituitary level and potentiation of arginine vasopressin-induced ACTH release. (1983) (90)
- Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I. (2008) (89)
- Evidence for Involvement of α-Adrenergic Receptors in Norepinephrine-Induced Prostaglandin E (1982) (87)
- Endogenous excitatory amino acids and glutamate receptor subtypes involved in the control of hypothalamic luteinizing hormone-releasing hormone secretion. (1992) (87)
- Pulsatile release of follicle-stimulating hormone in ovariectomized rats is inhibited by porcine follicular fluid (inhibin). (1984) (84)
- Evidence for a negative ultrashort loop feedback mechanism operating on the luteinizing hormone-releasing hormone neuronal system. (1987) (80)
- Metabolism of pro-luteinizing hormone-releasing hormone in immortalized hypothalamic neurons. (1991) (80)
- Modulation by dopamine and estradiol of the central effects of angiotensin II on anterior pituitary hormone release. (1982) (79)
- A Proof-of-Principle Clinical Trial of Bexarotene in Patients with Non–Small Cell Lung Cancer (2007) (75)
- Evidence for changes in sensitivity to testosterone negative feedback on gonadotropin release during sexual development in the male rat. (1973) (72)
- Arachidonic acid and its metabolites effects on testosterone production by rat Leydig cells (1995) (72)
- Different gamma-aminobutyric acid receptor subtypes are involved in the regulation of opiate-dependent and independent luteinizing hormone-releasing hormone secretion. (1989) (69)
- Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator. (2006) (67)
- Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein–protein interaction profile (2007) (67)
- Pulsatile follicle-stimulating hormone secretion is independent of luteinizing hormone-releasing hormone (LHRH): pulsatile replacement of LHRH bioactivity in LHRH-immunoneutralized rats. (1987) (67)
- Evidence for noradrenergic involvement in episodic prolactin and growth hormone release in ovariectomized rats. (1979) (65)
- Evidence that catecholaminergic and peptidergic (luteinizing hormone-releasing hormone) neurons in suprachiasmatic-medial preoptic, medial basal hypothalamus and median eminence are involved in estrogen-negative feedback. (1980) (65)
- New and improved glucocorticoid receptor ligands (2005) (64)
- Proopiomelanocortin-derived peptides in testicular interstitial fluid: characterization and changes in secretion after human chorionic gonadotropin or luteinizing hormone-releasing hormone analog treatment. (1986) (63)
- A Selective Retinoid X Receptor Agonist Bexarotene (Targretin) Prevents and Overcomes Acquired Paclitaxel (Taxol) Resistance in Human Non–Small Cell Lung Cancer (2004) (63)
- Cross-talk between excitatory and inhibitory amino acids in the regulation of luteinizing hormone-releasing hormone secretion. (1992) (63)
- Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile. (2002) (61)
- Inhibition of spontaneous or angiotensin II-stimulated water intake by atrial natriuretic factor (1985) (61)
- GAMMA aminobutyric acid (GABA), a modulator of anterior pituitary hormone secretion by hypothalamic and pituitary action (1984) (60)
- The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. (2006) (60)
- Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes. (1982) (58)
- Evidence for a pituitary site of action for the acute inhibition of LH release by estrogen in the rat. (1973) (57)
- Failure to detect radioimmunoassayable arginine vasotocin in mammalian pineals (1979) (57)
- Involvement of eicosanoids in release of oxytocin and vasopressin from the neural lobe of the rat pituitary. (1985) (56)
- Transmembrane signals mediating neural peptide secretion: role of protein kinase C activators and arachidonic acid metabolites in luteinizing hormone-releasing hormone secretion. (1986) (56)
- Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion. (1989) (56)
- A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours (2006) (55)
- LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo. (2008) (55)
- High concentrations of epinephrine derived from a central source and of 5-hydroxyindole-3-acetic acid in hypophysial portal plasma. (1983) (53)
- The effect of intraventricular gamma aminobutyric acid (GABA) on hypothalamic catecholamines and LHRH and on pituitary hormone release (1980) (52)
- Pulsatile luteinizing hormone (LH) patterns in ovariectomized rats: involvement of norepinephrine and dopamine in the release of LH-releasing hormone and LH. (1982) (52)
- Differential expression of gamma-aminobutyric acid receptors in immortalized luteinizing hormone-releasing hormone neurons. (1993) (51)
- Expression of Functional Estrogen Receptors and Galanin Messenger Ribonucleic Acid in Immortalized Luteinizing Hormone-Releasing Hormone Neurons: Estrogenic Control of Galanin Gene Expression. (1998) (51)
- Effects of sex and age on the growth hormone response to galanin in healthy human subjects. (1993) (51)
- Prostaglandin E2-induced luteinizing hormone-releasing hormone release involves mobilization of intracellular Ca+2. (1985) (51)
- Neurotransmitters in the Control of Anterior Pituitary Function (1979) (51)
- 1,2-Didecanoylglycerol and phorbol 12,13-dibutyrate enhance anterior pituitary hormone secretion in vitro. (1985) (50)
- Evidence for a hypothalamic site of action of inhibin to suppress FSH release. (1981) (50)
- Physiological role of galanin in the regulation of anterior pituitary function in humans. (1994) (49)
- Endogenous inhibin suppresses only basal follicle-stimulating hormone secretion but suppresses all parameters of pulsatile luteinizing hormone secretion in the diestrous female rat. (1989) (49)
- Acute ethanol treatment lowers hypophyseal portal plasma luteinizing hormone-releasing hormone (LH-RH) and systemic plasma LH levels in orchidectomized rats (1988) (49)
- Sexual dimorphism in copackaging of luteinizing hormone-releasing hormone and galanin into neurosecretory vesicles of hypophysiotrophic neurons: estrogen dependency. (1995) (49)
- Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence. (1983) (48)
- Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification. (2007) (48)
- Changes in brain somatostatin and vasopressin levels after stress in spontaneously hypertensive and Wistar-Kyoto rats (1980) (47)
- Evidence that inhibin plays a major role in the regulation of follicle-stimulating hormone secretion in the fully adult male rhesus monkey (Macaca mulatta). (1991) (46)
- The role of prostaglandins in the control of gonadotropin and prolactin secretion. (1979) (46)
- Neonatal imprinting predetermines the sexually dimorphic, estrogen-dependent expression of galanin in luteinizing hormone-releasing hormone neurons. (1993) (45)
- Development and characterization of a specific and sensitive radioimmunoassay for rat galanin: Measurement in brain tissue, hypophyseal portal and peripheral serum (1990) (45)
- Activation of gamma-aminobutyric acid B-receptors abolishes naloxone-stimulated luteinizing hormone release. (1987) (44)
- Effect of acute ether stress on monoamine metabolism in median eminence and discrete hypothalamic nuclei of the rat brain and on anterior pituitary hormone secretion. (1985) (43)
- Nitric Oxide Is Involved in the Genesis of Pulsatile LHRH Secretion from Immortalized LHRH Neurons (1997) (42)
- Maturation of the prolactin and proopiomelanocortin-derived peptide responses to ether stress and morphine: neurochemical analysis. (1986) (42)
- Regulation of luteinizing hormone-releasing hormone and luteinizing hormone secretion by hypothalamic amino acids. (1994) (42)
- Physiological Role of Peptides and Amines on the Regulation of ACTH Secretion (1987) (41)
- Estrogen activity and novel tissue selectivity of delta8,9-dehydroestrone sulfate in postmenopausal women. (1999) (41)
- Peptide hormones : effects and mechanisms of action (1988) (40)
- Effects of pituitary homografts on host pituitary prolactin and hypothalamic PIF levels. (1968) (40)
- Effects of starvation on hypothalamic FSH-RF and pituitary FSH in male rats. (1971) (39)
- Modulating Mechanisms of Neuroendocrine Cell Activity: The LHRH Pulse Generator (1998) (39)
- Evidence for involvement of alpha-adrenergic receptors in norepinephrine-induced prostaglandin E2 and luteinizing hormone-releasing hormone release from the median eminence. (1982) (39)
- Immunoneutralization of circulating inhibin in the hypophysiotropically clamped male rhesus monkey (Macaca mulatta) results in a selective hypersecretion of follicle-stimulating hormone. (1990) (38)
- Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): findings from a pilot study. (2007) (38)
- Physiologically important role for central oxytocin in the preovulatory release of luteinizing hormone (1990) (38)
- Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators. (2007) (37)
- On the hypothalamic mechanism by which prostaglandin E2 stimulates growth hormone release. In vivo and in vitro studies. (1980) (37)
- Endothelin-3 stimulates luteinizing hormone-releasing hormone (LHRH) secretion from LHRH neurons by a prostaglandin-dependent mechanism. (1993) (36)
- Ontogeny of gonadotropin, testosterone, and inhibin secretion in normal boys through puberty based on overnight serial sampling. (1995) (35)
- Partial characterization of immunoreactive substance P in the rat pituitary gland. (1984) (35)
- Role of central epinephrine on the regulation of corticotropin-releasing factor and adrenocorticotropin secretion. (1988) (35)
- The median eminence as a model to study presynaptic regulation of neural peptide release (1982) (34)
- Alterations in the responsiveness of median eminence luteinizing hormone-releasing hormone nerve terminals to norepinephrine and prostaglandin E2 in vitro during the rat estrous cycle. (1982) (34)
- Role of amygdaloid complex in sodium chloride and water intake in the rat (1968) (34)
- Expression of functional estrogen receptors and galanin messenger ribonucleic acid in immortalized luteinizing hormone-releasing hormone neurons: estrogenic control of galanin gene expression. (1998) (34)
- Modulation by galanin of growth hormone and gonadotropin secretion from perifused pituitary and median eminence of prepubertal male calves. (1997) (34)
- Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones. (2007) (33)
- Effects of starvation on plasma GH activity, pituitary GH and GH-RF levels in the rat. (1969) (32)
- Immortalized hypothalamic gonadotropin-releasing hormone neurons. (2007) (32)
- A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: improved physical functioning in the (2007) (32)
- The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells. (2005) (32)
- Increased responsiveness of the hypothalamic-pituitary axis after neurotoxin-induced hypothalamic denervation. (1984) (32)
- Arginine vasopressin and adrenocorticotropin release: correlation between binding characteristics and biological activity in anterior pituitary dispersed cells. (1984) (32)
- Neonatal monosodium glutamate treatment alters the response of median eminence luteinizing hormone-releasing hormone nerve terminals to potassium and prostaglandin E2. (1982) (31)
- Estimation of endogenous adrenocorticotropin half-life using pulsatility patterns: a physiological approach to the evaluation of secretory episodes. (1988) (31)
- Role of prostaglandins in the control of pituitary hormone secretion. (1978) (31)
- Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma. (2007) (31)
- A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) (2005) (31)
- Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones. (2007) (30)
- Testosterone selectively influences protein kinase-C-coupled secretion of proluteinizing hormone-releasing hormone-derived peptides. (1989) (30)
- Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones. (2007) (30)
- Destruction of testicular leydig cells reveals a role of endogenous inhibin in regulating follicle-stimulating hormone secretion in the adult male rat (1990) (29)
- Impact of the environment on reproductive health: executive summary. (1993) (29)
- Immunocytochemical localization of the gonadotropin-releasing hormone-associated peptide of the LHRH precursor. (1987) (29)
- Orchidectomy induces temporal and regional changes in the processing of the luteinizing hormone-releasing hormone prohormone in the rat brain. (1988) (29)
- A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. (2006) (28)
- Galanin-immunoreactive axons innervate somatostatin-synthesizing neurons in the anterior periventricular nucleus of the rat. (1993) (28)
- Diacylglycerol and phorbol esters enhance LHRH and prostaglandin E2 secretion from median eminence nerve terminals in vitro (1985) (26)
- Acute changes in norepinephrine content in the median eminence induced by orchidectomy or testosterone replacement. (1976) (25)
- A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) (2005) (25)
- Processing of the luteinizing hormone-releasing hormone precursor in the preoptic area and hypothalamus of the rat. (1988) (24)
- Identification of hypophysiotropic luteinizing hormone-releasing hormone (LHRH) neurons by combined retrograde labeling and immunocytochemistry. (2009) (24)
- Release of prostaglandin E2 from the hypothalamus depends on extracellular Ca2+ availability: relation to LHRH release. (1984) (23)
- Fertility after cryptorchidism: a comparative analysis of early orchidopexy with and without concomitant hormonal therapy in the young male rat. (1994) (23)
- Role of angiotensin II and vasopressin in cisplatin-induced emesis. (1990) (23)
- A sex difference in the activation of hypothalamic catecholaminergic and luteinizing hormone-releasing hormone peptidergic neurons after acute castration. (1982) (23)
- Transmembrane signals and intracellular messengers mediating LHRH and LH secretion. (1987) (22)
- Cellular mechanisms of acute estrogen negative feedback on LH secretion: Norepinephrine, dopamine and 5-hydroxytryptamine metabolism in discrete regions of the rat brain (1984) (22)
- Distinct pulsatile prolactin secretory patterns during the estrous cycle: possible encoding for diverse physiological responses. (1989) (22)
- Pituitary GH and hypothalamic GHRF after median eminence implantation of ovine or human GH. (1971) (21)
- Identification of polymorphisms associated with hypertriglyceridemia and prolonged survival induced by bexarotene in treating non-small cell lung cancer. (2011) (21)
- Gonadectomy influences the inhibitory effect of the endogenous opiate system on pulsatile gonadotropin secretion. (1988) (21)
- Efficacy and safety of denileukin diftitox (Dd) in a phase III, double-blind, placebo-controlled study of CD25+ patients with cutaneous T-cell lymphoma (CTCL) (2007) (20)
- Regulation and function of panhibin (somatostatin). (1980) (19)
- Immunohistochemical detection of proluteinizing hormone-releasing hormone peptides in neurons in the human hypothalamus. (1992) (19)
- Immunolocalization of inhibin alpha-subunit in the human testis. A light- and electron-microscopy study. (1992) (17)
- Role of gamma aminobutyric acid in control of anterior pituitary hormone release. (1981) (16)
- Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. (1992) (16)
- Adenosine receptor-dependent modulation of inhibin secretion in cultured immature rat Sertoli cells (1988) (16)
- Angiotensin II increases ACTH release in the absence of endogenous arginine-vasopressin. (1984) (15)
- Aging impairs galanin expression in luteinizing hormone-releasing hormone neurons: effect of ovariectomy and/or estradiol treatment. (1994) (15)
- Prolactin release after 5-hydroxytryptophan treatment requires an intact neurointermediate pituitary lobe. (1986) (15)
- Ontogeny of gonadotrophin and inhibin secretion in normal girls through puberty based on overnight serial sampling and a comparison with normal boys. (1997) (15)
- GABA and gonadotropin secretion: evidence from in vitro studies on regulation of LHRH secretion. (1986) (14)
- Cell-Specific Activation of the Human Skeletal α-Actin by Androgens (2008) (14)
- Aromatic L-amino acid decarboxylase activity in the rat median eminence, neurointermediate lobe and anterior lobe of the pituitary. Physiological and pharmacological implications for pituitary regulation. (1984) (14)
- Effects of neonatal monosodium glutamate (MSG) treatment on the hormonal and central monoaminergic dynamics associated with acute ether stress in the male rat (1984) (13)
- Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women. (1995) (13)
- A physiological role for sporadic interruptions of the dopaminergic tone in the genesis of big mass prolactin pulses. (1991) (13)
- Efficacy and safety of denileukin diftitox (Dd) in cutaneous T-cell lymphoma (CTCL) patients: Integrated analysis of three large phase III trials (2008) (13)
- The pro-LHRH system of the rat brain. effects of changes in the endocrine background (1988) (12)
- Immunocytochemical localization of the gonadotropin-releasing hormone-associated peptide portion of the LHRH precursor in the hypothalamus and extrahypothalamic regions of the rat central nervous system (2004) (12)
- Differential secretion of proLHRH fragments in response to [K+], prostaglandin E2 and C kinase activation (1988) (12)
- FSH-Releasing Factor Activity in Plasma of Rats After Hypophysectomy and Continuous Light1 (1968) (12)
- Steroid-monoamine feedback interactions in discrete brain regions using as a model the monosodium glutamate (MSG)-lesioned rat. (1984) (12)
- CHAPTER 5 – Male Neuroendocrinology and Endocrine Evaluation of Reproductive Disorders (1988) (11)
- Effect of central injection of bradykinin and bradykinin potentiating factor upon release of anterior pituitary hormones in ovariectomized female rats (1980) (11)
- Changes in catecholamine content of the median eminence precede the pro-oestrous surges of luteinizing hormone and prolactin. (1977) (11)
- Phase III Study of Denileukin Diftitox (ONTAK®) To Evaluate Efficacy and Safety in CD25+ and CD25- Cutaneous T-Cell Lymphoma (CTCL) Patients. (2006) (11)
- Role of adrenals in the changes of sodium chloride intake following lesions in the central nervous system. (1970) (11)
- Peptide-steroid interactions in brain regulation of pulsatile gonadotropin secretion. (1986) (10)
- 5(Z)-benzylidene-1,2-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5H-1-aza-6-oxa-chrysenes as non-steroidal glucocorticoid receptor modulators. (2007) (10)
- Thyrotropin and prolactin secretion are not affected by porcine and rat galanin in normal subjects. (1992) (10)
- Hypothalamic control of gonadotrophin and prolactin secretion, implications for fertility control. (1973) (10)
- Cell-specific activation of the human skeletal alpha-actin by androgens. (2008) (10)
- Changes in hypothalamic FSH-RF and pituitary FSH during the estrous cycle of rats. (1970) (9)
- Pretreatment with phorbol ester and an LHRH agonist reduces testosterone production and protein kinase C activity in rat Leydig cells challenged with PDBu and LHRH. (1996) (9)
- Combined antibody-high-performance liquid chromatography approach to assess prohormone processing. (1989) (9)
- How does the gonad affect LHRH secretion? Effects of gonadectomy on LHRH release from median eminence nerve terminals incubated in vitro and on LHRH concentration in hypophyseal portal blood. (1987) (9)
- CHAPTER 7 – Hypothalamic Control of LHRH and Somatostatin: Role of Central Neurotransmitters and Intracellular Messengers (1980) (9)
- Inhibitory effect on LH release of estradiol injected into the third ventricle. (1974) (9)
- Computer-controlled perifusion system for neuroendocrine tissues: development and applications. (1986) (9)
- Passive immunoneutralization: a method for studying the regulation of basal and pulsatile hormone secretion. (1989) (9)
- Removal of plasma FSH-RF activity in hypophysectomized rats by testosterone propionate or reserpine. (1968) (8)
- A female-like rise in luteinizing hormone and follicle-stimulating hormone after gonadectomy in male rats induced by oestradiol pretreatment. (1979) (8)
- Male reproduction and fertility (1983) (8)
- Effect of aromatizable androgens and estradiol on prolactin secretion in prepuberal male rats. (1979) (8)
- Andrology and Human Reproduction (1988) (8)
- EVIDENCE FOR THE ABSENCE OF ARGININE VASOTOCIN IN MAMMALIAN PINEALS, INCLUDING THE BRATTLEBORO RAT (1982) (8)
- Effects of Continuous Light on Hypothalamic FSH-Releasing Factor and Pituitary FSH Levels in Rats∗ (1968) (7)
- ON THE ROLE OF ARGININE VASOPRESSIN IN CIRCUMVENTRICULAR ORGANS (1982) (7)
- Abstract CN04-04: Phase II trial of bexarotene in women at high risk of breast cancer: Comparison of protein and RNA biomarkers (2008) (7)
- Hypophysiotropic hormones of the hypothalamus. (1981) (7)
- Steroid imprinting and modulation of sexual dimorphism in the luteinizing hormone-releasing hormone neuronal system (1996) (7)
- Pulsatile peptide secretion: encoding of brain messages regulating endocrine and reproductive functions. (1987) (7)
- Estrogenic feminization of the LH response to orchidectomy in the rat: evidence for a hypothalamic site of action. (1982) (7)
- Neurotoxin effects on oxytocin, vasopressin and somatostatin in discrete rat brain areas (1986) (6)
- Peptide Binding Identifies an ERα Conformation That Generates Selective Activity in Multiple In Vitro Assays (2005) (6)
- Effects of injection of anti-luteinizing hormone (LH)-releasing hormone serum and anti-gonadotropin-releasing hormone-associated peptide serum into neonatal rats on LH and follicle-stimulating hormone cells. (1993) (6)
- Involvement of arachidonic acid metabolites in the control of hypothalamic-pituitary function. (1985) (6)
- Interactions between lhrh analogs and pro-opiomelanocortin-derived peptides of testicular origin to modulate gonadal endocrine function (1984) (6)
- Effect of independent deafferentation of each border of the medial basal hypothalamus on catecholamine content of the median eminence and on serum LH and prolactin levels in ovariectomized rats (1978) (6)
- CHAPTER 3 – Regulation of the Hypothalamic–Pituitary–Gonadal Axis: Role of Gonadal Steroids and Implications for the Menopause (2000) (6)
- Cyclic GMP and cyclic AMP levels in median eminence, hypothalamus and pituitary gland of the rat after decapitation or microwave irradiation (1979) (6)
- Immunolocalization of inhibin α-subunit in the human testis (1992) (5)
- A proof-of-principle trial of bexarotene in patients (pts) with resectable non-small cell lung cancer (NSCLC) (2005) (5)
- New Progestins and Potential Actions (2000) (4)
- In vitro release of somatostatin and LRH by MBH and ME fragments: effect of catecholamines (CA's) (1978) (4)
- Differential effect of neurointermediate lobectomy on central oxytocin and vasopressin (1990) (4)
- Women’s Health in the Next Millennium: Endocrinology Is Leading the Way (1999) (4)
- Effect of ventral noradrenergic bundle lesions on concentrations of monoamine neurotransmitters and metabolites in several discrete areas of the rat brain (1987) (4)
- Components of metabolic syndrome correlate with longer survival in NSCLC in bexarotene-treated patients with high hypertriglyceridemia in SPIRIT I and II trials: A retrospective analysis. (2006) (4)
- Activity and Tissue Selectivity of Delta8,9 Dehydroestrone Sulfate in Postmenopausal Women: P-59. (1996) (4)
- Inhibin: central and peripheral effects to regulate follicle-stimulating hormone secretion. (1983) (4)
- Proceedings: Interaction between gonadal steroids and LH-releasing hormone to control gonadotropin secretion at the pituitary level. (1973) (4)
- A retinoid X receptor (RXR)-selective agonist bexarotene produces synergistic growth inhibitory activity with gefitinib in non-small-cell lung cancer (NSCLC) cell lines. (2004) (3)
- New progestins and potential actions. (2000) (3)
- (827): Oral once-a-day AVINZA (morphine sulfate extended-release capsules) vs. twice daily OxyContin (oxycodone hydrochloride controlled-release) for the treatment of chronic moderate-to-severe low back pain; final (part I and part II) study results (2006) (3)
- Control of gonadotropin secretion by brain amines and peptides. (1982) (3)
- (813): Oral once-a-day AVINZA (morphine sulfate extended-release capsules) vs. twice daily OxyContin (oxycodone hydrochloride controlled-release): A randomized, multicenter study for the treatment of chronic moderate to severe low back pain (2006) (2)
- Orchidectomy induces temporal and regional changes in the synthesis and processing of the LHRH prohormone in the rat brain. (1987) (2)
- (820): Once-a-day AVINZA vs. twice daily OxyContin® in an open-label extension (part II) to the ACTION trial for the treatment of chronic moderate-to-severe low back pain (2006) (2)
- Biomarker correlates of survival in NSCLC: Role of RXRβ and PPARγ in mediating bexarotene impact on patient survival. (2006) (1)
- Cooperative antitumor activity between the retinoid X receptor (RXR)-selective agonist bexarotene and EGFR-tyrosine kinase inhibitors in preclinical models of NSCLC. (2006) (1)
- (865): Significant improvements in neurocognition observed in once-a-day Avinza (extended release morphine sulfate) treated patients with chronic moderate to severe osteoarthritis (OA) pain (2006) (1)
- Once-a-day AVINZA® improves sleep quality measurements (polysomnographic and subjective) in patients treated for chronic moderate to severe Osteoarthritis (OA) pain (2005) (1)
- Bexarotene prevents and reverses gemcitabine resistance in non-small-cell lung cancer cells by affecting gene amplification. (2006) (1)
- Reproduction, Growth and Development (1991) (1)
- In vitro assay for growth hormone releasing factor (GHRF). (1969) (1)
- PSH-releasing factor activity in plasma of rats after hypophysectomy and continuous light. (1968) (1)
- The combination of a Retinoid X Receptor (RXR) agonist LGD1069 (bexarotene) and vinorelbine produce synergistic growth inhibitory activity in non-small-cell lung cancer (NSCLC) cell lines (2004) (1)
- Steroid effects on hypothalamic-gonadotropin interactions. (1981) (1)
- Possible role of phosphatidylserine on luteinizing hormone releasing hormone, arginine vasopressin, oxytocin and prostaglandin E2 secretion by rat median eminence nerve terminals in vitro (1988) (1)
- Mechanisms regulating LHRH release: implications for fertility regulation (1984) (1)
- PUTATIVE SYNAPTIC TRANSMITTERS INVOLVED IN THE CONTROL OF GONADOTROPIN AND GROWTH HORMONE RELEASE (1981) (1)
- Cellular mechanisms of acute estrogen negative feedback on LH secretion: pituitary responsiveness to LHRH and estradiol receptor kinetics in the pituitary, preoptic hypothalamic area, and the caudal hypothalamic area of the rat brain. (1985) (1)
- The Effects of Intraventricular Injection of Antibiotics on LH Release in the Rat (1974) (0)
- P-562 Evaluation of bexarotene (Targretine®) in combination with cisplatin and vinorelbine in chemotherapy-naïve patients with advanced stage IIIb/IV non-small cell lung cancer (NSCLC) (2005) (0)
- Cell-Specific Activation of the Human Skeletal (cid:1) -Actin by Androgens (2008) (0)
- O-086 A phase III randomized trial of carboplati/paclitaxel, with or without bexarotene (Targretin®), in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) (2005) (0)
- Endocrine Reviews: A Peer-Reviewed Journal (1993) (0)
- Tissueand CellularDistributionoftheExtended Family ofProteinKinase C Isoenzymes (1992) (0)
- Dissociated effect of buserelin on luteinizing hormone (LH) and alpha subunit in men (1990) (0)
- D. treatment approach (medical/interventional)D14 - opioid: Clinical pharmacology(795): Once-a-day Avinza effects on sleep (polysomnographic and subjective quality measurements) in patients treated for chronic moderate to severe osteoarthritis (OA) pain (2006) (0)
- International Society of Endocriology (2004) (0)
- On the dopaminergic-serotoninergic interactions in the regulation of prolactin secretion in male rats (1978) (0)
- Current concepts of the hypothalamic control of follicle-stimulating hormone secretion. (1990) (0)
- Searching For SARA (2004) (0)
- The specific activity of delta‐8,9‐dehydroestrone on bone resorption and other physiological properties associated with menopause (2000) (0)
- Estrogenic feminization of the LH response to orchidectomy: association with prolonged nuclear estradiol receptor retention and induction of cytoplasmic progestin receptors in brain and pituitary. (1986) (0)
- Contents, Vol. 37, 1983 (1983) (0)
- Subject Index Vol. 37, 1983 (1983) (0)
- The combination of a Retinoid X Receptor (RXR) agonist LGD1069 (bexarotene) and vinorelbine produce synergistic growth inhibitory activity in non-small-cell lung cancer (NSCLC) cell lines. (2004) (0)
- Recent developments in the endocrine regulation of the male gonad. (1990) (0)
- Control of Gonadotropin and Prolactin Secretion by Hypothalamic Releasing and Inhibiting Hormones (1974) (0)
- 47 – Computer-Controlled Perifusion System for Neuroendocrine Tissues: Development and Applications (1989) (0)
- P-954 Preoperative bexarotene in patients with resectable non-smallcell lung cancer (NSCLC): A proof-of-principle study (2005) (0)
- Cellular and Molecular Aspects of LHRH Secretion and Bioactivity (1992) (0)
This paper list is powered by the following services:
